隆凸性皮肤纤维肉瘤
Dermatofibrosarcoma protuberans
定义 英文原文(暂无中文)
Dermatofibrosarcoma protuberans (DFSP) is a rare infiltrating soft tissue sarcoma, generally of low grade malignancy, arising from the dermis of the skin and characteristically associated with a specific chromosomal translocation t(17;22).
别名
DFSP
基本事实
- 遗传方式
- 不适用
- 发病年龄
- 各年龄段
- 患病率
- 1-5 / 10 000(Europe)
相关基因 2
| 基因 | 名称 | 关联类型 |
|---|---|---|
| COL1A1 | collagen type I alpha 1 chain | Part of a fusion gene in |
| PDGFB | platelet derived growth factor subunit B | Part of a fusion gene in |
临床表型 8
极常见 99–80%5
- 红斑 HP:0010783
- 纤维肉瘤 HP:0100244
- 皮肤肿瘤 HP:0008069
- 皮下结节 HP:0001482
- 皮肤增厚 HP:0001072
常见 79–30%1
- 皮肤溃疡 HP:0200042
偶见 29–5%1
- 疼痛 HP:0012531
罕见 <4–1%1
- 淋巴结肿大 HP:0002716
近两年的全球研究 720L2
2024/08 起在 Europe PMC 检索所得,按发表时间倒序显示最近 20 篇。标题未译成中文——自动翻译需要接入 LLM 服务,尚未引入。
- 2026-08病例报告Lesions Reported as Plaque-Like CD34-Positive Dermal Fibroma Reveal Two Reproducible Clinicopathologic Patterns: Two Cases and Literature Review
- 2026-08病例报告PDGFD-Rearranged Dermatofibrosarcoma Protuberans With S100 and Pan-TRK Expression
- 2026-07A High-Grade CD34-Positive Spindle Cell Sarcoma of the Palm Revealing an Unexpected TPM3::NTRK1 Fusion: A Diagnostic Pitfall With Major Therapeutic Implications
- 2026-07病例报告Dermatofibrosarcoma protuberans following penetrating trauma: Case report
- 2026-07Diagnostic Pitfalls of Morphological Mimicry and CD34 Heterogeneity in Recurrent or Fibrosarcomatous Dermatofibrosarcoma Protuberans: A Clinicopathological Analysis of Three Molecularly Confirmed Cases With Literature Review
- 2026-07Tumor Characteristics, Subclinical Extent, and Time to Poor Outcomes for less Common Skin Cancers
- 2026-07Recurrent TNC::PDGFD Fusions in Ossifying Plexiform Tumors of the Skin
- 2026-07Mechanism of MEK1 phosphorylation by the N-terminal acidic motif-mediated asymmetric BRAF dimer
- 2026-07病例报告Fibrosarcomatous Transformation of Recurrent Thigh Dermatofibrosarcoma Protuberans Presenting With Spontaneous Hemorrhage
- 2026-07Impact of Dermatology Access on Dermatofibrosarcoma Protuberans Outcomes
- 2026-07MRI-Based Surgical Margin Assessment in Dermatofibrosarcoma Protuberans: Correlation With Pathological Extent
- 2026-07综述Mechanisms of Local Aggressiveness Without Metastasis in Dermatofibrosarcoma Protuberans
- 2026-07Neoadjuvant BO-112 and Hypofractionated Radiation Therapy with or without Nivolumab in Soft-Tissue Sarcoma: Preclinical and Phase I Results
- 2026-06Proteomics-based approach reveals the involvement of spliceosomal components SF3B and SerpinB9 in dermatofibrosarcoma protuberans
- 2026-06Congenital Atrophic Dermatofibrosarcoma Protuberans: A Case Report and Narrative Review of the Literature
- 2026-06病例报告The 'CIED Team' Approach to Device-Related Complications
- 2026-06Colonic metastasis of dermatofibrosarcoma protuberans detected by colonoscopy
- 2026-06开放获取Sorafenib Restores Pentose Phosphate Pathway-Related Redox Homeostasis via the c-Raf/HSP90/G6PD Axis in Hepatic Ischemia-Reperfusion Injury
- 2026-06病例报告Spindle cell hemangioma of the lower abdominal wall mimicking dermatofibrosarcoma protuberans: A case report
- 2026-06病例报告Durable control of recurrent dermatofibrosarcoma protuberans using wide-margin Mohs micrographic surgery and flap reconstruction without adjuvant radiotherapy: a case report and literature review
境外已获批用于本病的药物 1L2
欧盟 0 项、美国 1 项。同一药物在两地各批一次的,会分别列出。
「境外已获批」不等于「在中国能用」。中间隔着进口注册、临床急需境外新药通道、海南博鳌乐城国际医疗旅游先行区等几条路径,各有各的条件与费用。这一节能确定地告诉你的只有一件事:这个病在世界范围内已经有获得批准的药物,它叫什么名字。拿这个名字去问主治医生,是下一步最省力的做法。
药名一律保留英文原文,不作翻译——中国的药品通用名与英文名的音译经常不一致,译错会让人去找一个不存在的药。
- Gleevec美国2006-10-19imatinib mesylate官方记录
数据来自欧洲药品管理局(EMA)的药品与孤儿药资格公开导出表,以及美国 FDA 孤儿药资格数据库。两边口径不同:欧盟一侧取的是当前状态仍为「已授权」的药品;美国一侧记录的是「曾获批准」这一事实,FDA 的公开表不追踪药物此后是否退市(例如 Relyvrio 于 2024 年撤市,表中仍记为已获批)。请以官方记录页为准。
中国境外的在招试验 9L2
这些试验在中国没有研究中心,通常无法直接报名——入组一般要求在当地居住并接受随访。列在这里是因为它另有用处:看清楚全世界正在试哪些药、做到了哪一期、由谁在做。把药名和 NCT 编号记下来去问主治医生,或据此进一步查该药是否已在境外获批、是否有拓展性用药(expanded access)通道。
共 9 项。
- 尚未开始招募NCT07646080Exploratory Study on Toripalimab and Anlotinib Combined With Standard Chemotherapy for Refractory Dermatofibrosarcoma Protuberans
- 招募中NCT07173972Dose-escalated, Hypofractionated, Definitive Proton Radiotherapy for Patients With Inoperable Soft Tissue Sarcoma.挪威
- 招募中NCT07169344Hypofractionated, 3-week, Preoperative Proton or X-ray Radiotherapy for Patients With Localized Soft Tissue Sarcoma挪威
- 尚未开始招募NCT06526897Evaluation of Chest CT Versus Chest X-Ray for Lung Surveillance After Curative-Intent Resection of High-Risk Truncal-Extremity Soft Tissue Sarcoma
- 招募中NCT06789172A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors澳大利亚、英国、美国
- 尚未开始招募NCT06610071NIFR Image-guided Surgery for Malignant Soft Tissue Tumor With Low-dose SWIG Technique
- 招募中NCT06239272NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)美国
- 招募中NCT05711615Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma美国
- 招募中NCT04332874A Study of Pembrolizumab Plus Local Chemotherapy Using Isolated Limb Infusion (ILI) for Patients With Sarcoma in the Arm or Leg美国
外部标识与链接
发现这一页有错误?告诉我 · 邮件主题会自动带上本页的 ORPHA 编号
本页数据来源
- 疾病定义、同义词、基因、表型、流行病学:Orphanet(CC BY 4.0)
- 中文病名:Orphanet 中文包,冻结于 2020-06-01
- 表型中文标签:HPO 简体中文翻译(CHPO 上游成果)